04 September 2020>: Original Paper
Transplantation of a Novel Recombinant Adeno-Associated Virus (pAAV-HE1B19K-TE1A) Demonstrates Higher Anti-Tumor Effects in Tumor Cells
Zhuo-Qing Li 1BCDEF* , Hong Shen 2BCDE* , Kun-Xian Shu 3BCDF , Jian-Jun Li 1BCDF , Yin Tang 4BCD , Jing-Jing Su 4BCF , Jun Yan 1BCD , Jie Yang 3BCF , Ze-Qing Wang 1BCF , Yan Qiu 4BC , Yong Yang 1CF , Yang Liu 4CF , Yong Zhou 5BDEG*DOI: 10.12659/AOT.925013
Ann Transplant 2020; 25:e925013
Figure 8 HE staining for analyzing pathological changes of vital organs of mice after pAAV-HE1B19K-TE1A injection and in the vital organs of normal mice. For the pAAV-HE1B19K-TE1A-injected mice, at 2 weeks after injection, the tissues (heart, liver, spleen, lung, and kidney) were collected for toxicity evaluation. Magnification, 400×.